Search Results Search Sort by RelevanceMost Recent History of Medicine May 2024 A Brief History of Antimicrobial Resistance Devin Hunt and Olivia S. Kates, MD, MA Resistance has dogged infectious disease treatment processes since we started using modern antimicrobials. AMA J Ethics. 2024;26(5):E408-417. doi: 10.1001/amajethics.2024.408. Case and Commentary May 2024 How Should We Manage Antimicrobial Resistance in Resource-Limited Settings? Elizabeth A. Gulleen, MD and Margaret Lubwama, MBChB, MMed Patients living in low-and middle-income countries (LMICs) shoulder the greatest burden of infections caused by antimicrobial-resistant pathogens. AMA J Ethics. 2024;26(5):E373-379. doi: 10.1001/amajethics.2024.373. Case and Commentary Nov 2008 Ethics of Expedited Partner Therapy, Commentary 1 Matthew R. Golden, MD, MPH and Matthew Hogben, PhD Using expedited partner therapy to treat certain STDs entails clinical and ethical risks and benefits. Virtual Mentor. 2008;10(11):708-715. doi: 10.1001/virtualmentor.2008.10.11.ccas3-0811. Case and Commentary Nov 2008 Ethics of Expedited Partner Therapy, Commentary 2 Mark A. Levine, MD Using expedited partner therapy to treat certain STDs entails clinical and ethical risks and benefits. Virtual Mentor. 2008;10(11):708-718. doi: 10.1001/virtualmentor.2008.10.11.ccas3-0811. Policy Forum Oct 2005 From Research to Policy: Expedited Partner Therapy for Chlamydia Jeffrey D. Klausner, MD, MPH Research is critical to the development of public policy as it relates to the need for expedited therapy for the partners of patients with a sexually transmitted disease. Virtual Mentor. 2005;7(10):693-696. doi: 10.1001/virtualmentor.2005.7.10.pfor1-0510. Pagination First page « First Previous page ‹ Previous Page 1 Current page 2
History of Medicine May 2024 A Brief History of Antimicrobial Resistance Devin Hunt and Olivia S. Kates, MD, MA Resistance has dogged infectious disease treatment processes since we started using modern antimicrobials. AMA J Ethics. 2024;26(5):E408-417. doi: 10.1001/amajethics.2024.408.
Case and Commentary May 2024 How Should We Manage Antimicrobial Resistance in Resource-Limited Settings? Elizabeth A. Gulleen, MD and Margaret Lubwama, MBChB, MMed Patients living in low-and middle-income countries (LMICs) shoulder the greatest burden of infections caused by antimicrobial-resistant pathogens. AMA J Ethics. 2024;26(5):E373-379. doi: 10.1001/amajethics.2024.373.
Case and Commentary Nov 2008 Ethics of Expedited Partner Therapy, Commentary 1 Matthew R. Golden, MD, MPH and Matthew Hogben, PhD Using expedited partner therapy to treat certain STDs entails clinical and ethical risks and benefits. Virtual Mentor. 2008;10(11):708-715. doi: 10.1001/virtualmentor.2008.10.11.ccas3-0811.
Case and Commentary Nov 2008 Ethics of Expedited Partner Therapy, Commentary 2 Mark A. Levine, MD Using expedited partner therapy to treat certain STDs entails clinical and ethical risks and benefits. Virtual Mentor. 2008;10(11):708-718. doi: 10.1001/virtualmentor.2008.10.11.ccas3-0811.
Policy Forum Oct 2005 From Research to Policy: Expedited Partner Therapy for Chlamydia Jeffrey D. Klausner, MD, MPH Research is critical to the development of public policy as it relates to the need for expedited therapy for the partners of patients with a sexually transmitted disease. Virtual Mentor. 2005;7(10):693-696. doi: 10.1001/virtualmentor.2005.7.10.pfor1-0510.